Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

Non-V600E BRAF mutations and treatment for Hairy Cell Leukemia

Evgeny Arons, Chin-Hsien Tai, Joshi Suraj, Yuelin Liu, Chi-Ping Day, Mark Raffeld, Liqiang Xi, Mory Gould, Isaac David Shpilman, Christopher C. Oakes, Seema Ali Bhat, Michael Rhodes Grever, Daniel Jones, Kerry A Rogers, Hao-Wei Wang, Constance M Yuan, S. Cenk Sahinalp, Robert J. Kreitman

Blood blood.2024026894.

https://doi.org/10.1182/blood.2024026894

Published: 2024

Includes: Supplemental data

Journal Articles

Non-V600E BRAF Gene Alterations in Hairy Cell Leukemia

Evgeny Arons, Chin-Hsien Tai, Suraj Joshi, Yuelin Liu, Chi-ping Day, Mark Raffeld, Liqiang Xi, Hong Zhou, Mory Gould, Isaac Shpilman, Christopher C. Oakes, Seema A Bhat, Michael R. Grever, Kerry A. Rogers, Hao-Wei Wang, Constance M. Yuan, Cenk Sahinalp, Robert J. Kreitman

Blood (2024) 144 (Supplement 1): 1586.

https://doi.org/10.1182/blood-2024-204016

Published: 2024

Journal Articles

A Randomized Phase 2 Trial of 2nd-Line Cladribine with Concurrent or Delayed Rituximab in Patients with Classic Hairy Cell Leukemia

Robert J. Kreitman, Hao-Wei Wang, Dana I. Delgado Colon, Hong Zhou, Evgeny Arons, Mark Raffeld, Liqiang Xi, Julie Feurtado, Lacey James, Raul C. Braylan, Katherine R. Calvo, Irina Maric, Constance M. Yuan

Blood (2024) 144 (Supplement 1): 863.

https://doi.org/10.1182/blood-2024-202793

Published: 2024

Journal Articles

Rituximab Reduces Immunogenicity and Increases Complete Remissions without Minimal Residual Disease in Relapsed/Refractory Hairy Cell Leukemia Patients Receiving Moxetumomab Pasudotox

Robert J. Kreitman, Constance M. Yuan, Hao-Wei Wang, Hong Zhou, Mark Raffeld, Liqiang Xi, Evgeny Arons, Julie Feurtado, Lacey James, Raul C. Braylan, Katherine R. Calvo, Irina Maric, Ira Pastan

Blood (2024) 144 (Supplement 1): 6791.

https://doi.org/10.1182/blood-2024-199569

Published: 2024

Journal Articles

Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant

Dai Chihara, MD PhD, Evgeny Arons, PhD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Hao-Wei Wang, MD PhD, Hong Zhou, Mark Raffeld, MD, Liqiang Xi, MD, Seth M. Steinberg, PhD, Julie Feurtado, RN, Lacey James-Echenique, CRNP, Wyndham Wilson, MD, Raul C. Braylan, MD, Katherine R. Calvo, MD PhD, Irina Maric, MD MSci, Alina Dulau-Florea, MD, Robert J. Kreitman, MD

Blood (2019) 134 (Supplement_1): 1536.

https://doi.org/10.1182/blood-2019-124515

Published: 2019

Journal Articles

Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

Chingiz Underbayev, MD PhD, Inhye E Ahn, MD, Hailey Harris, Lauren T Vaughn, Mehdi Pirooznia, MD PhD, Liqiang Xi, MD, Mark Raffeld, MD, Sarah E. M. Herman, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 1287.

https://doi.org/10.1182/blood-2019-127364

Published: 2019

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Recurrent somatic JAK3 mutations in NK-cell enteropathy

Wenbin Xiao, Gaurav K. Gupta, Jinjuan Yao, Yoon J. Jang, Liqiang Xi, Jeeyeon Baik, Allison Sigler, Anita Kumar, Alison J. Moskowitz, Maria E. Arcila, Mark Raffeld, Stefania Pittaluga, Ahmet Dogan, Elaine S. Jaffe

Blood (2019) 134 (12): 986–991.

https://doi.org/10.1182/blood.2019001443

Published: 2019

Includes: Supplemental data

Journal Articles

CREBBP gene mutations are frequently detected in in situ follicular neoplasia

Janine Schmidt, Joan Enric Ramis-Zaldivar, Irina Bonzheim, Julia Steinhilber, Inga Müller, Andrea Haake, Shan Chi Yu, Mark Raffeld, Falko Fend, Itziar Salaverria, Reiner Siebert, Elaine S. Jaffe, Leticia Quintanilla-Martinez

Blood (2018) 132 (25): 2687–2690.

https://doi.org/10.1182/blood-2018-03-837039

Published: 2018

Includes: Supplemental data

Journal Articles

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Blood (2017) 129 (11): 1469–1479.

https://doi.org/10.1182/blood-2016-06-719294

Published: 2017

Includes: Supplemental data

Journal Articles

Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea

Chi A. Ma, Liqiang Xi, Brian Cauff, Adam DeZure, Alexandra F. Freeman, Sophie Hambleton, Gary Kleiner, T. Ronan Leahy, Maureen O’Sullivan, Michelle Makiya, Grainne O’Regan, Stefania Pittaluga, Julie Niemela, Jennifer Stoddard, Sergio D. Rosenzweig, Mark Raffeld, Amy D. Klion, Joshua D. Milner

Blood (2017) 129 (5): 650–653.

https://doi.org/10.1182/blood-2016-09-737817

Published: 2017

Includes: Supplemental data

Journal Articles

Hodgkin Lymphoma Variant of Richter Transformation: Morphology, EBV Status, Clonality and Survival Analysis a Retrospective Study of 77 Patients

Wenbin Xao, MD PhD, Wayne Chen, MD PhD, Lynn Sorbara, PhD, Theresa Davies-Hill, Stefania Pittaluga, MD PhD, Mark Raffeld, MD, Elaine S Jaffe, MD

Blood (2015) 126 (23): 2637.

https://doi.org/10.1182/blood.V126.23.2637.2637

Published: 2015

Journal Articles

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment

Alina Nicolae, Stefania Pittaluga, Shahed Abdullah, Seth M. Steinberg, Thu Anh Pham, Theresa Davies-Hill, Liqiang Xi, Mark Raffeld, Elaine S. Jaffe

Blood (2015) 126 (7): 863–872.

https://doi.org/10.1182/blood-2015-02-630632

Published: 2015

Includes: Supplemental data

Journal Articles

Series of Hairy Cell Leukemia Patients with Co-Existent Plasma Cell Disorders

Neha Korde, MD, Sham Mailankody, MD, Evgeny Arons, PhD, Raul C. Braylan, MD, Mark Raffeld, MD, Elizabeth Maestri, RN, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Ola Landgren, MD PhD, Irina Maric, MD, Robert J. Kreitman, MD

Blood (2014) 124 (21): 5647.

https://doi.org/10.1182/blood.V124.21.5647.5647

Published: 2014

Journal Articles

Identification of a Subset of Peripheral T-Cell Lymphoma, Not Otherwise Specified, Characterized By FOXP3-Positive Regulatory T-Cell Phenotype, HTLV-1 Negativity and Poor Outcome

Martin Bjerregaard Pedersen, Stephen Jacques Hamilton-Dutoit, Knud Bendix, Peter H. Nørgaard, Møller Boe Michael, Mark Raffeld, Stefania Pittaluga, Torben Steiniche, Anke Bergmann, Inga Vater, Reiner Siebert, Wing-Chung Chan, Francesco d'Amore

Blood (2014) 124 (21): 1616.

https://doi.org/10.1182/blood.V124.21.1616.1616

Published: 2014

Journal Articles

Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome

Amy D. Klion, Rojelio Mejia, Edward W. Cowen, Kennichi C. Dowdell, Kieron Dunleavy, Gary A. Fahle, Nicole Holland-Thomas, Irina Maric, Stefania Pittaluga, Mark Raffeld, Carlo Santos, Maryalice Stetler-Stevenson, Tammy Krogmann, Amber N. Shatzer, Siu-Ping Turk, Yuzhi Yin, Liqiang Xi, Calman Prussin, Jeffrey I. Cohen

Blood (2013) 121 (12): 2364–2366.

https://doi.org/10.1182/blood-2012-12-472720

Published: 2013

Journal Articles

Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia

Thomas A. Waldmann, Kevin C. Conlon, Donn M. Stewart, TatYana A. Worthy, John E. Janik, Thomas A. Fleisher, Paul S. Albert, William D. Figg, Shawn D. Spencer, Mark Raffeld, Jean R. Decker, Carolyn K. Goldman, Bonita R. Bryant, Michael N. Petrus, Stephen P. Creekmore, John C. Morris

Blood (2013) 121 (3): 476–484.

https://doi.org/10.1182/blood-2012-08-450585

Published: 2013

Includes: Supplemental data

Journal Articles

Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox.

Robert J. Kreitman, MD, Evgeny Arons, PhD, Sapolsky Jeffrey, Laura Roth, Hong Zhou, BS, Maryalice Stetler-Stevenson, MD, PhD, Wyndham H. Wilson, MD, PhD, Mark Raffeld, MD, David J. P. FitzGerald, PhD, Ji Fei, PhD, Ramy Ibrahim, MD, Ira Pastan, MD

Blood (2012) 120 (21): 2896.

https://doi.org/10.1182/blood.V120.21.2896.2896

Published: 2012

Journal Articles

B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma

Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, MD, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, MD, James N. Kochenderfer

Blood (2012) 120 (21): 937.

https://doi.org/10.1182/blood.V120.21.937.937

Published: 2012

Journal Articles

Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients

Blood (2012) 120 (21): 732.

https://doi.org/10.1182/blood.V120.21.732.732

Published: 2012

NARROW

Non-V600E BRAF mutations and treatment for Hairy Cell Leukemia

Non-V600E BRAF Gene Alterations in Hairy Cell Leukemia

A Randomized Phase 2 Trial of 2nd-Line Cladribine with Concurrent or Delayed Rituximab in Patients with Classic Hairy Cell Leukemia

Rituximab Reduces Immunogenicity and Increases Complete Remissions without Minimal Residual Disease in Relapsed/Refractory Hairy Cell Leukemia Patients Receiving Moxetumomab Pasudotox

Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant

Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Recurrent somatic JAK3 mutations in NK-cell enteropathy

CREBBP gene mutations are frequently detected in in situ follicular neoplasia

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea

Hodgkin Lymphoma Variant of Richter Transformation: Morphology, EBV Status, Clonality and Survival Analysis a Retrospective Study of 77 Patients

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment

Series of Hairy Cell Leukemia Patients with Co-Existent Plasma Cell Disorders

Identification of a Subset of Peripheral T-Cell Lymphoma, Not Otherwise Specified, Characterized By FOXP3-Positive Regulatory T-Cell Phenotype, HTLV-1 Negativity and Poor Outcome

Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome

Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia

Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox.

B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma

Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only